OTHR-09. The prevalence and complex management of MEK inhibitor induced cutaneous side effects

BACKGROUND: Cutaneous side effects commonly occur with MEK inhibitor (MEKi) therapy and can be challenging to manage. METHODS: A retrospective chart review was performed on sixteen pediatric patients treated with MEKi therapy for at least three months. These patients were diagnosed with either a bra...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Ashley, Ogle, Andrea, Shatara, Margaret, Cantor, Evan, Cluster, Andrew, McHugh, Michele, Beck, Mary, Reiners, Stephanie, Coughlin, Carrie, Abdelbaki, Mohamed, Brossier, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Others (Not Fitting Any Other Category)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165008/
http://dx.doi.org/10.1093/neuonc/noac079.548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165008/
http://dx.doi.org/10.1093/neuonc/noac079.548

Ejemplares similares